Navigation Links
HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid-Beta Accumulation, a Hallmark of Alzheimer's Disease
Date:9/3/2009

NAPLES, Fla., Sept. 3 /PRNewswire/ -- Alzheimer's disease is the most common cause of dementia among the elderly and is projected to increase in prevalence over the next decades as the population ages -- creating an urgent need for treatments that will prevent or reverse the now-inexorable course of cognitive deterioration and memory loss. Because development of synthetic drugs is expensive and complex, many researchers are focusing on botanical extracts whose benefits have been documented by traditional medicine systems. In that vein, scientists with HerbalScience Group LLC, working with researchers from other organizations and medical institutions, conducted an in-depth study of optimized turmeric extracts, demonstrating that key bioactives in the botanical extracts inhibit aggregation and release of amyloid, a protein fragment considered a prime causal suspect in Alzheimer's disease.

An article detailing the study, titled "Optimized Turmeric Extracts Have Potent Anti-Amyloidogenic Effects," will be published in the December 2009 issue of Current Alzheimer's Research, a peer-reviewed scientific journal. The authors are affiliated with several research organizations and medical institutions, including HerbalScience Group LLC; the University of Miami Leonard M. Miller School of Medicine, Miami, Florida; the University of South Florida College of Medicine, Tampa, Florida; Veterans Administration Hospital, Research Service, Tampa, Florida; and Natura Therapeutics, Tampa, Florida.

"The optimized extracts outperformed curcumin, the best studied anti-Alzheimer extract from turmeric," said Randall S. Alberte, Ph.D., one of the authors of the study and Chief Scientific Officer of HerbalScience Group LLC, a Naples, Florida, and Singapore-based company dedicated to applying advanced science and technology to the production of botanical drugs and nutraceuticals.

For the research, three standardized turmeric extracts were prepared that were enriched in curcuminoids and turmerones, two major classes of compounds present in turmeric. Each of the three proprietary extracts had a different chemical profile and was standardized using advanced extraction technology developed by HerbalScience to create herbal extracts that are dose-reliable and efficacious. The activities of the extracts were compared to standard curcuminoids.

Inhibition of amyloid aggregation and secretion was studied in vitro among the different extracts and standards, and it was found that one of the extracts had the greatest activity in inhibiting the aggregation and secretion of amyloid. This extract, containing the highest levels of curcuminoids among all of the extracts, demonstrated activity that was significantly greater than curcumin alone, the most active of the four curcuminoid standards. This result indicates that an enriched turmeric extract could be just as or more effective than curcumin, the most commonly studied turmeric material for Alzheimer's disease.

The HerbalScience study also used advanced DART (Direct Analysis in Real Time) Time-of-Flight mass spectrometry technology to generate detailed chemical profiles of each extract in order to determine the key bioactive compounds. Only 5% of the compounds were known chemicals, with the remaining 95% being identified for the first time. With further chemical analysis and identification of key bioactives, highly standardized extracts such as these could offer a rich new source for potential drug discovery for Alzheimer's and other therapeutic targets.

The journal article detailing the study will appear in the December 2009 issue of Current Alzheimer's Research (Vol. 6, No. 6). Authors are R. Douglas Shytle, Paula C. Bickford, Kavon Rezai-zadeh, L Hou, Jin Zeng, Jun Tan, and Paul Sanberg, with University of South Florida College of Medicine affiliations including the Department of Neurosurgery Center for Excellence in Aging and Brain Repair, Department of Psychiatry and Behavioral Medicine Silver Child Development Center, and Neuroscience Program; Cyndy D. Sanberg of Natura Therapeutics, Inc., Tampa, Florida; Bill Roschek Jr. and Randall S. Alberte, of HerbalScience Group LLC, Naples, Florida; and Ryan C. Fink, Department of Biochemistry and Molecular Biology, The University of Miami Leonard M. Miller School of Medicine, Miami, Florida. Dr. Bickford is also affiliated with the Veterans Administration Hospital, Research Service, Tampa, Florida; and Drs. Shytle, Bickford, Tan, and Paul Sanberg are also affiliated with Natura Therapeutics.

HerbalScience is a privately-held life sciences company headquartered in Naples, Florida, with facilities in Singapore. HerbalScience is engaged in the discovery, development, manufacture, and marketing of proprietary botanical compounds for human health in the U.S. and international markets. The company has prominent alliances with prestigious university laboratories and prominent researchers in the U.S., as well as research institutions in China.


'/>"/>
SOURCE HerbalScience Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. HerbalScience Research Identifies Key Bioactives in Nettle Extract That Inhibit Inflammation Associated with Seasonal Allergies
2. HerbalScience Research Identifies Specific Bioactives In Stabilized Rice Bran Extract that Impart Anti-Inflammatory Benefits
3. NutraCea Forms Joint Ventures With HerbalScience to Develop Nutraceutical Extracts and Pharmaceutical Chemistries From Stabilized Rice Bran
4. Sensory Research Center Benefit Concert Yields Scholarships for Autistic Children
5. Fox Chase Cancer Center receives $8 million NIH grant to expand laboratory animal research facility
6. University of Georgia researchers show component of mothballs is present in deep-space clouds
7. Biomedical Research Centre developing enhanced cells as therapies
8. Video: Physical and Mental Health of U.S. Warfighter Is Focus of Military Health Research Forum
9. Researchers link inflammatory diseases to increased cardiovascular risk
10. AMR Research Analyst Named One of the Most Inspiring Individuals in Life Sciences by PharmaVOICE
11. Research Supports Improving Scoring of Costs and Benefits of Preventive Health Care to Better Inform Federal Budgetary Decisions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, ... ... School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, ... professionals on guideline updates for the primary prevention of cardiovascular diseases during ...
(Date:10/13/2017)... ... 13, 2017 , ... Many families have long-term insurance that covers care for ... a waiver for care if the client has a cognitive impairment diagnosis. , ... care, is often waived, so the benefits from their insurance start immediately,” said Mechell ...
(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids this ... by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited about ... ages; it is a non-competitive, non-timed event, which is all about having fun and ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/12/2017)... WILMINGTON, Del. (PRWEB) , ... October 12, 2017 ... ... technology and advisory services for healthcare compliance program management, will showcase a range ... and National Association for Assisted Living (NCAL) Convention and Expo to be held ...
Breaking Medicine News(10 mins):
(Date:10/5/2017)... Ill. , Oct. 5, 2017  In ... Association of Oral and Maxillofacial Surgeons (AAOMS) released ... opioids – to be used as a first-line ... pain. Recognizing ... the AAOMS White Paper "Opioid Prescribing: Acute and ...
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and ... financial results for the third quarter of 2017 on ... conference call on that day with the investment community ... The conference call will begin at 9 ... can access a live webcast of the conference call ...
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
Breaking Medicine Technology: